BRIEF published on 05/27/2025 at 08:50, 1 year 1 month ago Lhyfe's General Meeting Approves Key Resolutions Green Hydrogen Corporate Governance Shareholder Meeting Board Appointments Financial Approval
BRIEF published on 05/27/2025 at 08:50, 1 year 1 month ago L'assemblée générale de Lhyfe approuve les résolutions clés Gouvernance D'Entreprise Hydrogène Vert Approbation Financière Nominations Au Conseil D'administration Assemblée Des Actionnaires
BRIEF published on 05/27/2025 at 08:40, 1 year 1 month ago Outokumpu City Council Approves Zoning for Hautalampi Project Sustainable Mining Eurobattery Minerals Battery Minerals Hautalampi Project Zoning Approval
BRIEF published on 05/27/2025 at 08:40, 1 year 1 month ago Le conseil municipal d'Outokumpu approuve le zonage du projet Hautalampi Eurobattery Minerals Minéraux Pour Batteries Exploitation Minière Durable Projet Hautalampi Approbation De Zonage
BRIEF published on 05/27/2025 at 08:37, 1 year 1 month ago PNE AG Introduces Wattmate for Enhanced Electricity Marketing Renewable Energy PNE AG Power Purchase Agreements Wattmate Launch Electricity Marketing
BRIEF published on 05/27/2025 at 08:37, 1 year 1 month ago PNE AG présente Wattmate pour une commercialisation améliorée de l'électricité Énergie Renouvelable PNE AG Lancement De Wattmate Commercialisation De L'électricité Accords D'achat D'électricité
BRIEF published on 05/27/2025 at 08:30, 1 year 1 month ago AI in Job Applications: Potential Unmet and Individuality Lost AI In Hiring Job Application Quality Recruitment Trends Skills Mismatch Authenticity In Applications
BRIEF published on 05/27/2025 at 08:30, 1 year 1 month ago L'IA dans les candidatures : potentiel non exploité et individualité perdue L'IA Dans Le Recrutement Qualité Des Candidatures Tendances En Matière De Recrutement Inadéquation Des Compétences Authenticité Des Candidatures
BRIEF published on 05/27/2025 at 08:12, 1 year 1 month ago Heidelberg Pharma Begins Phase I Study for HDP-102 in Non-Hodgkin Lymphoma Heidelberg Pharma ADC Technology HDP-102 Non-Hodgkin Lymphoma Phase I Study
BRIEF published on 05/27/2025 at 08:12, 1 year 1 month ago Heidelberg Pharma lance une étude de phase I pour le HDP-102 dans le lymphome non hodgkinien Heidelberg Pharma Technologie ADC HDP-102 Lymphome Non Hodgkinien Étude De Phase I
Published on 07/25/2026 at 00:35, 1 day 18 hours ago Pathfinder Ventures Inc. Provides Corporate Update
Published on 07/24/2026 at 23:00, 1 day 20 hours ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 1 day 21 hours ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 1 day 21 hours ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 1 day 23 hours ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/26/2026 at 19:12, 16 minutes ago EQS-Adhoc: Kapsch TrafficCom reaches agreement with its major financial creditors on key terms of a restructuring.
Published on 07/26/2026 at 18:46, 41 minutes ago EQS-Adhoc: Kapsch TrafficCom reaches agreement with its major financial creditors on key terms of a restructuring.
Published on 07/24/2026 at 18:50, 2 days ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 18:50, 2 days ago Déclaration hebdomadaire d'opérations effectuées du 20 au 24 juillet 2026
Published on 07/24/2026 at 18:23, 2 days 1 hour ago Communiqué relatif au dépôt d'offre publique de retrait visant les actions Bourrelier Group
